Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05888350Not ApplicableCompleted

Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.

Role: collaborator

NCT07308743Not ApplicableNot Yet Recruiting

Impact of Computer-aided Detection System on the Proximal Adenoma Miss Rate

Role: collaborator

NCT06162780Recruiting

TEER for Severe DMR of Low to Intermediate Surgery Risk

Role: collaborator

NCT04885738Unknown

The Value of FeNO in Predicting Airway Eosinophilic Inflammation

Role: collaborator

All 4 trials loaded